Skip to main content
. Author manuscript; available in PMC: 2021 Jun 2.
Published in final edited form as: Radiographics. 2021 Feb 5;41(2):321–337. doi: 10.1148/rg.2021200101

Figure 3.

Figure 3.

Images from the Hologic Dimensions DBT system, which was approved by the FDA in 2011. Mediolateral oblique two-dimensional mammogram (a), synthetic C-view image (b), and in-plane DBT image (c) of the left breast in a 40-year-old woman at baseline screening show diagnostic-quality images of a small spiculated mass (arrow) that was biopsy proven to be a grade 1 ER+/PR+/HER2− invasive ductal carcinoma.